Home > Journals > Minerva Obstetrics and Gynecology > Past Issues > Minerva Ginecologica 2004 February;56(1) > Minerva Ginecologica 2004 February;56(1):27-40

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  POLYCYSTIC OVARY SYNDROME 

Minerva Ginecologica 2004 February;56(1):27-40

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence

Talbott E. O., Zborowski V. J., Boudraux M. Y.


PDF


Polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder found in ~5% of the general population and is characterized by chronic anovulation, hyperandrogenism, and insulin resistance. Women with PCOS are at increased risk for the development of Type II diabetes and may represent a unique group of women at high risk for the development of coronary heart disease (CHD). More adverse CHD risk profiles of women with PCOS have been demonstrated in several studies, yet actual health outcome studies have been inconclusive as to whether this translates into increased rates of cardiovascular disease in PCOS cases when compared to controls. This review focuses on the controversy surrounding the potential relationship between cardiovascular disease outcomes and polycystic ovary syndrome.

top of page